Building the first truly integrated longevity ecosystem — combining regenerative biotech, AI, and next-gen clinics into a global platform.
“We are not here to slow aging.We are here to reverse it.
Celljevity is pioneering the shift from reactive medicine to proactive healthspan optimization, using the best of stem cell science, AI, and elite clinical care.
A world where aging is not inevitable decline, but a treatable condition. Where health is personalized, predictive, and preventive.
Not an inevitable decline, but a biological process we can influence
Every individual deserves treatment tailored to their unique biology
Advanced science should be accessible, not confined to laboratories
Over 1,000 patients treated with measurable results
37 patients
56 patients
80 patients
31 patients
Note: Preliminary observational outcomes. Results require validation in randomized controlled trials. Individual results may vary. These statistics represent patient-reported improvements and clinical observations, not FDA-approved treatment claims.
Scientific Breakthrough
World's Most Advanced Autologous Rejuvenation Protocol
Using a patient's own cells to reverse biological age without editing DNA or using CRISPR. A proprietary 15-day treatment that rejuvenates cellular aging markers at the fundamental level.
+32%
Telomere Extension
0+
Patients Treated
0
Adverse Events
Technology, Clinics & AI —
One Unified Platform
Celljevity unites three pillars to deliver proactive longevity: Prometheus cell rejuvenation, flagship clinics across Europe and the Middle East, and an AI Health Twin Platform that creates a personalized care loop that doesn't just treat symptoms — it prevents them.
Global Clinic Network
Temples of Transformation
These are not medical offices. They are sanctuaries where science meets soul, where cutting-edge regenerative medicine is delivered in environments designed for total rejuvenation.
French Riviera
Clinique DelMar
Where luxury meets regenerative medicine on the stunning Côte d'Azur. Our flagship facility combines Mediterranean serenity with cutting-edge cellular therapies, offering the complete Prometheus protocol in an environment designed for healing.
Middle East Hub
ZOIME
Multi-omics diagnostics meets elite biohacking in the heart of innovation. Advanced genomic profiling, metabolomic analysis, and personalized optimization protocols delivered with Middle Eastern hospitality and cutting-edge technology.
City of Light
Maison Epigenetic
Where epigenetic optimization meets emotional longevity. Combining Parisian elegance with breakthrough therapies that address both biological and psychological aspects of aging.
Global Expansion
New York, London, Tokyo, and Singapore. Bringing the Celljevity experience to major cities worldwide, each clinic collecting proprietary data to continuously improve our protocols.
Integrated Ecosystem
The first truly integrated longevity platform — connecting your health data, treatment protocols, and clinical insights into one intelligent system that knows you better than any doctor could.
Online • Prometheus Protocol Active
Can you show me the latest results from my Prometheus treatment? How are my telomeres responding?
2:34 PM
Excellent news! Your latest biomarker analysis shows remarkable progress:
Biological Age
42 (-8 years)
Cell Viability
97% optimal
Your cells are responding exceptionally well to the treatment. The rejuvenation markers are all trending positive.
2:34 PM
That's amazing! When is my next clinic visit scheduled?
2:35 PM
Your next appointment is confirmed:
Clinique DelMar
Antibes, French Riviera
December 15, 2024 • 10:00 AM
Treatment: Prometheus Protocol - Phase 3
I've also prepared your personalized protocol adjustments based on your latest results. Would you like to review them?
AI is analyzing your data...
The Process
A small skin biopsy collected under local anesthesia in our clinical facilities.
15 minutes
Fibroblasts isolated and expanded in GMP-certified laboratories using proprietary protocols.
7-10 days
Proprietary 15-day treatment reverses cellular aging markers without genetic modification.
15 days
20 billion rejuvenated cells delivered via targeted injection for systemic benefits.
1 hour
Current Step
A small skin biopsy collected under local anesthesia in our clinical facilities.
Leading publications recognize our breakthrough in cellular rejuvenation technology
As Featured In
Celljevity's innovative approach to making advanced cellular therapies accessible to broader populations through strategic partnerships and global expansion.
Revolutionary cellular reprogramming technology shows promising results in reversing biological aging markers and restoring cellular function.
Former trader turned biotech entrepreneur Diederik van der Reijt leads breakthrough developments in cellular rejuvenation technology at Celljevity.
CEO Diederik van der Reijt discusses Celljevity's vision for revolutionizing healthcare through cellular therapy and the company's ambitious growth plans.
Our multidisciplinary team spans executive leadership, scientific research, medical advisory, and strategic guidance — united in revolutionizing human longevity through cutting-edge cellular therapies.
Our core leadership team driving Celljevity's mission forward with decades of combined experience in biotechnology, medicine, and business innovation.
Chief Executive Officer
Visionary leader driving Celljevity's mission to revolutionize cellular regeneration and human longevity.
Chief Business Officer
Strategic business leader focused on scaling Celljevity's global operations and partnerships.
Chief Medical Officer
Distinguished physician and researcher specializing in clinical immunology, transfusion medicine, and clinical genetics. Graduate of University of Amsterdam with extensive experience in biotechnology entrepreneurship and co-founder of 15+ biotech companies.
Chief Integration Officer
Integration leader ensuring seamless coordination across Celljevity's global operations and technology platforms.
Chief Operational Officer
Operations expert ensuring seamless delivery of Celljevity's cutting-edge cellular therapies worldwide.
Chief Technology Officer
Technology innovator building the digital infrastructure powering Celljevity's AI-driven health platform.
Chief Growth Officer
Growth strategist expanding Celljevity's reach and impact in the global longevity market.
Chief Artificial Intelligence Architect
CEO of Erasmus.AI and creator of domain-specific AI models such as ClimateGPT. Member of OECD's AI Expert Group and Club of Rome with over 25 years of experience in global strategy and foresight advisory.
Supporting our mission with specialized expertise across operations, finance, and regional leadership.
Finance Director
Financial leader managing Celljevity's strategic investments and sustainable growth initiatives.
President MENA Operations
Regional leader expanding Celljevity's presence across the Middle East and North Africa.
Life Sciences Director
Life sciences expert advancing Celljevity's research and development initiatives.
President Morocco Operations
Regional operations leader expanding Celljevity's presence in North Africa.
Technology Director
Technology director driving innovation in Celljevity's digital health solutions.
President EU Operations
Regional operations leader expanding Celljevity's presence across Europe.
Distinguished experts and thought leaders providing strategic guidance and clinical expertise to advance our mission.
Professor, Tonji University
Renowned professor contributing expertise in regenerative medicine research.
Clinical Director, UCLA
UCLA Clinical Director contributing research expertise in cellular medicine.
Board-Certified Physician
Board-certified physician providing clinical expertise in regenerative therapies.
Founder, Clinic Del Mar
Founder of Clinic Del Mar, pioneering advanced medical treatments and patient care.
Cardiologist & Anti-Aging Physician
Specialized cardiologist and anti-aging physician advancing longevity medicine.
Medical Advisor
Professor of Orthopedics and Traumatology with over 25 years of experience in joint replacement surgery and sports medicine. Fellow at Hospital for Special Surgery (New York) and member of the American Academy of Orthopedic Surgeons.
Strategic Advisor
Strategic advisor specializing in healthcare innovation and market development.
Senior Advisor
Senior advisor contributing strategic insights for Celljevity's growth initiatives.
Non-Executive Director
Non-executive director providing independent oversight and strategic guidance.
Strategic Advisor
Strategic advisor providing guidance on global market expansion and business development.
Strategic Advisor
Strategic advisor providing guidance on business development and strategic initiatives.
Strategic Advisor
Strategic advisor providing expertise in European healthcare markets and operations.
Investment Advisor
Co-founder of GCW Global Customised Wealth specializing in private equity and family office investments. Brings deep healthcare investment expertise to the team.
Executive Board Member
Executive board member contributing strategic leadership and governance expertise.
XPRIZE Healthspan Semi-Finalist • UCLA Research Partnership • 9+ Patents
For investor inquiries and roadshow reservations
Medical Disclaimer: Celljevity's Prometheus technology is currently investigational and not approved by the FDA. Treatment availability varies by jurisdiction. Individual results may vary. Please consult with your healthcare provider. The statements on this website have not been evaluated by the Food and Drug Administration. Our treatments are not intended to diagnose, treat, cure, or prevent any disease.
